Ironwood Pharmaceuticals Inc
IRWDNasdaqCIK 1446847HealthcareFiscal year ends Dec 31
Reports and events: 293 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1611:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-116423 |
| 2026-08-0620:07 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-091987 |
| 2026-08-0611:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-091625 |
| 2026-06-1820:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-075730 |
| 2026-06-1520:05 ET | 8-K | 8.01 Other events | 0001104659-26-074023 |
| 2026-05-2120:05 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001104659-26-065140 |
| 2026-05-1312:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-26-059814 |
| 2026-05-0720:08 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-057110 |
| 2026-05-0711:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-056656 |
| 2026-04-2820:06 ET | DEF 14A | Proxy statementPeriod 2026-06-16 | 0001104659-26-050325 |
| 2026-03-1922:35 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000899140-26-000333 |
| 2026-03-1111:05 ET | 8-K | 8.01 Other events | 0001104659-26-026123 |
| 2026-02-2621:09 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-020489 |
| 2026-02-2512:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-019405 |
| 2026-01-0212:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-000057 |
| 2025-12-2312:06 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-123974 |
| 2025-11-2612:00 ET | 8-K | 8.01 Other events | 0001104659-25-116217 |
| 2025-11-1012:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-108806 |
| 2025-11-1012:01 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-108795 |
| 2025-10-1011:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-098523 |
| 2025-09-0320:05 ET | 8-K | 8.01 Other events | 0001104659-25-087008 |
| 2025-08-1120:13 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-011050 |
| 2025-08-0711:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-074972 |
| 2025-07-1020:06 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001104659-25-066986 |
| 2025-06-1220:17 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-058883 |
| 2025-06-0320:05 ET | 8-K | 3.01 Delisting notice | 0001104659-25-055958 |
| 2025-05-1220:36 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-007406 |
| 2025-05-0711:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-045310 |
| 2025-04-2821:27 ET | DEF 14A | Proxy statementPeriod 2025-06-10 | 0001104659-25-040309 |
| 2025-04-2511:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-039013 |
| 2025-04-1411:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-034381 |
| 2025-03-3111:07 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-004072 |
| 2025-03-2720:05 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-028766 |
| 2025-02-2712:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-017774 |
| 2025-01-2921:10 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors | 0001104659-25-007212 |
| 2024-12-0522:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-24-125937 |
| 2024-11-1221:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-24-116764 |
| 2024-11-0722:22 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-014909 |
| 2024-11-0712:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-115052 |
| 2024-09-3011:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-103925 |
| 2024-08-0820:06 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-011590 |
| 2024-08-0811:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-086992 |
| 2024-06-2111:30 ET | 8-K | 5.07 Shareholder vote results | 0001104659-24-073736 |
| 2024-06-2020:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001104659-24-073391 |
| 2024-05-0920:46 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-007640 |
| 2024-05-0911:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-059101 |
| 2024-04-2520:26 ET | DEF 14A | Proxy statementPeriod 2024-06-18 | 0001104659-24-051992 |
| 2024-02-1612:01 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-001275 |
| 2024-02-1512:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-024345 |
| 2024-01-0811:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-001989 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.